Back
Coherus Oncology Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
CHRS
Coherus Oncology
Last Price:
$0.90
Seasonality Move:
2.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CHRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Coherus Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.86 | Buy |
20-day SMA: | 0.8 | Buy |
50-day SMA: | 0.82 | Buy |
200-day SMA: | 1.03 | Sell |
8-day EMA: | 0.73 | Buy |
20-day EMA: | 0.44 | Buy |
50-day EMA: | 0.21 | Buy |
200-day EMA: | 0.06 | Buy |
Coherus Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 58 | Buy |
Chaikin Money Flow: | 1228313 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.74 - 0.86) | Buy |
Bollinger Bands (100): | (0.77 - 1.01) | Buy |
Coherus Oncology Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Coherus Oncology Stock
Is Coherus Oncology Stock a Buy?
-
Coherus Oncology share price is 0.90 while CHRS 8-day simple moving average is 0.86, which is a Buy signal.
-
The stock price of CHRS is 0.90 while Coherus Oncology 20-day SMA is 0.80, which makes it a Buy.
-
Coherus Oncology 50-day simple moving average is 0.82 while CHRS share price is 0.90, making it a Buy technically.
-
CHRS stock price is 0.90 and Coherus Oncology 200-day simple moving average is 1.03, creating a Sell signal.
CHRS Technical Analysis vs Fundamental Analysis
Sell
41
Coherus Oncology (CHRS)
is a Sell
Is Coherus Oncology a Buy or a Sell?
-
Coherus Oncology stock is rated a SellThe current Coherus Oncology [CHRS] share price is $0.90. The Score for CHRS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Coherus Oncology Stock Info
Market Cap:
104.3M
Price in USD:
0.90
Share Volume:
1.2M
Coherus Oncology 52-Week Range
52-Week High:
2.43
52-Week Low:
0.66
Sell
41
Coherus Oncology (CHRS)
is a Sell
Coherus Oncology Share Price Forecast
-
What is the Coherus Oncology stock price today?The Coherus Oncology stock price is 0.90 USD today.
-
Will CHRS stock go up or go down?Coherus Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Coherus Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Coherus Oncology is overvalued.
Is Coherus Oncology Stock a Buy?
-
Coherus Oncology share price is 0.90 while CHRS 8-day exponential moving average is 0.73, which is a Buy signal.
-
The stock price of CHRS is 0.90 while Coherus Oncology 20-day EMA is 0.44, which makes it a Buy.
-
Coherus Oncology 50-day exponential moving average is 0.21 while CHRS share price is 0.90, making it a Buy technically.
-
CHRS stock price is 0.90 and Coherus Oncology 200-day simple moving average is 0.06, creating a Buy signal.
Fundamental Analysis of Coherus Oncology
Is Coherus Oncology a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.33 per share.
Technical Analysis of Coherus Oncology
Should I short Coherus Oncology stock?
-
CHRS Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Coherus Oncology is a Buy
-
Coherus Oncology Relative Strength Index (RSI) is 58, which suggest Coherus Oncology is overbought
-
The Bollinger Bands (25) for Coherus Oncology is (0.74 - 0.86), which suggest Coherus Oncology is a Buy
-
The Bollinger Bands (100) for Coherus Oncology is (0.77 - 1.01), which suggest Coherus Oncology is a Buy
* Coherus Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.